$59.83
Live
0.24%
Downside
Day's Volatility :0.87%
Upside
0.63%
41.65%
Downside
52 Weeks Volatility :44.76%
Upside
5.33%
Period | Astrana Health Inc | Index (Russel 2000) |
---|---|---|
3 Months | 21.89% | 0.0% |
6 Months | 61.88% | 0.0% |
1 Year | 95.89% | 0.0% |
3 Years | -15.75% | -23.0% |
Market Capitalization | 2.8B |
Book Value | $14.28 |
Earnings Per Share (EPS) | 1.44 |
PE Ratio | 42.08 |
PEG Ratio | 0.0 |
Wall Street Target Price | 60.26 |
Profit Margin | 4.3% |
Operating Margin TTM | 6.18% |
Return On Assets TTM | 5.23% |
Return On Equity TTM | 12.54% |
Revenue TTM | 1.6B |
Revenue Per Share TTM | 33.86 |
Quarterly Revenue Growth YOY | 39.6% |
Gross Profit TTM | 199.5M |
EBITDA | 117.2M |
Diluted Eps TTM | 1.44 |
Quarterly Earnings Growth YOY | 0.43 |
EPS Estimate Current Year | 1.27 |
EPS Estimate Next Year | 1.63 |
EPS Estimate Current Quarter | 0.39 |
EPS Estimate Next Quarter | 0.48 |
What analysts predicted
Upside of 0.72%
FY18 | Y/Y Change | |
---|---|---|
Revenue | 519.9M | ↑ 45.33% |
Net Income | 10.8M | ↓ 58.01% |
Net Profit Margin | 2.08% | ↓ 5.13% |
FY19 | Y/Y Change | |
---|---|---|
Revenue | 560.6M | ↑ 7.83% |
Net Income | 14.1M | ↑ 30.29% |
Net Profit Margin | 2.52% | ↑ 0.44% |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 370.2M | ↓ 33.96% |
Net Income | -23.8M | ↓ 268.26% |
Net Profit Margin | -6.42% | ↓ 8.94% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 773.9M | ↑ 109.03% |
Net Income | 68.9M | ↓ 390.18% |
Net Profit Margin | 8.91% | ↑ 15.33% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 1.1B | ↑ 47.84% |
Net Income | 45.2M | ↓ 34.46% |
Net Profit Margin | 3.95% | ↓ 4.96% |
FY23 | Y/Y Change | |
---|---|---|
Revenue | 1.4B | ↑ 21.19% |
Net Income | 60.7M | ↑ 34.42% |
Net Profit Margin | 4.38% | ↑ 0.43% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Revenue | 337.2M | ↑ 14.63% |
Net Income | 13.1M | ↓ 605.08% |
Net Profit Margin | 3.89% | ↑ 4.77% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 348.2M | ↑ 3.25% |
Net Income | 13.2M | ↑ 0.29% |
Net Profit Margin | 3.78% | ↓ 0.11% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Revenue | 348.2M | ↓ 0.01% |
Net Income | 22.1M | ↑ 67.49% |
Net Profit Margin | 6.34% | ↑ 2.56% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Revenue | 353.0M | ↑ 1.4% |
Net Income | 12.4M | ↓ 43.99% |
Net Profit Margin | 3.5% | ↓ 2.84% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Revenue | 404.4M | ↑ 14.54% |
Net Income | 14.8M | ↑ 20.06% |
Net Profit Margin | 3.67% | ↑ 0.17% |
Q2 FY24 | Q/Q Change | |
---|---|---|
Revenue | 486.3M | ↑ 20.26% |
Net Income | 19.2M | ↑ 29.23% |
Net Profit Margin | 3.94% | ↑ 0.27% |
FY18 | Y/Y Change | |
---|---|---|
Total Assets | 513.0M | ↑ 4.56% |
Total Liabilities | 106.3M | ↓ 31.09% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 728.7M | ↑ 42.05% |
Total Liabilities | 367.7M | ↑ 245.74% |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 817.5M | ↑ 12.18% |
Total Liabilities | 372.3M | ↑ 1.27% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 867.4M | ↑ 6.1% |
Total Liabilities | 356.7M | ↓ 4.19% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 966.2M | ↑ 11.4% |
Total Liabilities | 407.7M | ↑ 14.28% |
FY23 | Y/Y Change | |
---|---|---|
Total Assets | 933.4M | ↓ 3.4% |
Total Liabilities | 522.6M | ↑ 28.19% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 992.6M | ↑ 0.27% |
Total Liabilities | 414.7M | ↓ 3.86% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 1.0B | ↑ 3.48% |
Total Liabilities | 443.6M | ↑ 6.96% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 1.1B | ↑ 4.49% |
Total Liabilities | 457.6M | ↑ 3.17% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 933.4M | ↓ 13.04% |
Total Liabilities | 522.6M | ↑ 14.2% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 1.2B | ↑ 31.38% |
Total Liabilities | 773.9M | ↑ 48.08% |
Q2 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 1.3B | ↑ 2.14% |
Total Liabilities | 773.8M | ↓ 0.01% |
FY18 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 26.1M | ↓ 50.82% |
Investing Cash Flow | -25.2M | ↓ 415.94% |
Financing Cash Flow | -11.2M | ↓ 25.19% |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 13.7M | ↓ 47.62% |
Investing Cash Flow | -180.6M | ↑ 617.28% |
Financing Cash Flow | 163.3M | ↓ 1557.84% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 46.2M | ↑ 237.61% |
Investing Cash Flow | 95.5M | ↓ 152.87% |
Financing Cash Flow | -51.7M | ↓ 131.65% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 70.3M | ↑ 52.36% |
Investing Cash Flow | 16.5M | ↓ 82.68% |
Financing Cash Flow | -47.7M | ↓ 7.64% |
FY22 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 82.1M | ↑ 16.77% |
Investing Cash Flow | -7.1M | ↓ 143.0% |
Financing Cash Flow | -20.1M | ↓ 57.94% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 7.7M | ↓ 90.91% |
Investing Cash Flow | -14.0M | ↓ 206.32% |
Financing Cash Flow | -7.1M | ↓ 220.92% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 25.8M | ↑ 234.22% |
Investing Cash Flow | -14.0M | ↑ 0.0% |
Financing Cash Flow | -963.0K | ↓ 86.43% |
Sell
Neutral
Buy
Astrana Health Inc is currently in a neutral trading position according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
Astrana Health Inc | 6.24% | 61.88% | 95.89% | -15.75% | 305.56% |
Fresenius Medical Care Ag | 1.13% | -0.24% | 18.22% | -43.13% | -40.13% |
Hca Holdings, Inc. | 2.43% | 33.91% | 72.47% | 59.82% | 236.17% |
Tenet Healthcare Corp. | -2.48% | 72.77% | 199.8% | 132.6% | 569.4% |
Universal Health Services Inc. | -1.63% | 46.88% | 89.37% | 72.31% | 62.86% |
Davita Healthcare Partners Inc. | 0.24% | 22.22% | 105.36% | 40.34% | 176.12% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
Astrana Health Inc | 42.08 | 42.08 | 0.0 | 1.27 | 0.13 | 0.05 | NA | 14.28 |
Fresenius Medical Care Ag | 20.24 | 20.24 | 0.41 | 2.52 | 0.05 | 0.03 | 0.03 | 47.48 |
Hca Holdings, Inc. | 19.51 | 19.51 | 1.23 | 22.62 | 0.74 | 0.11 | 0.01 | -6.17 |
Tenet Healthcare Corp. | 5.89 | 5.89 | 0.83 | 10.57 | 0.55 | 0.07 | NA | 36.27 |
Universal Health Services Inc. | 17.4 | 17.4 | 1.87 | 15.93 | 0.15 | 0.06 | 0.0 | 97.21 |
Davita Healthcare Partners Inc. | 17.05 | 17.05 | 1.53 | 9.8 | 0.45 | 0.07 | NA | 7.44 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
Astrana Health Inc | Buy | $2.8B | 305.56% | 42.08 | 4.3% |
Fresenius Medical Care Ag | Hold | $11.8B | -40.13% | 20.24 | 2.73% |
Hca Holdings, Inc. | Buy | $107.2B | 236.17% | 19.51 | 8.4% |
Tenet Healthcare Corp. | Buy | $15.5B | 569.4% | 5.89 | 13.18% |
Universal Health Services Inc. | Hold | $15.8B | 62.86% | 17.4 | 6.22% |
Davita Healthcare Partners Inc. | Hold | $13.4B | 176.12% | 17.05 | 6.86% |
Insights on Astrana Health Inc
Revenue is up for the last 4 quarters, 348.17M → 486.26M (in $), with an average increase of 10.3% per quarter
Netprofit is up for the last 3 quarters, 12.35M → 19.17M (in $), with an average increase of 19.7% per quarter
In the last 1 year, Tenet Healthcare Corp. has given 200.3% return, outperforming this stock by 107.9%
In the last 3 years, Tenet Healthcare Corp. has given 132.6% return, outperforming this stock by 148.4%
BlackRock Inc
Vanguard Group Inc
State Street Corp
Geode Capital Management, LLC
Dimensional Fund Advisors, Inc.
Steel Peak Wealth Management LLC
apollo medical holdings, inc., a physician-centric technology-powered healthcare management company, provides medical care services. the company, leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver quality care to its patients. it offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. the company's physician network consists of primary care physicians, specialist physicians, and hospitalists. it caters to patients, primarily covered by private or public insurance, such as medicare, medicaid, and health maintenance organization plans; and non-insured patients in california. apollo medical holdings, inc. was founded in 1994 and is headquartered in alhambra, california.
Organization | Astrana Health Inc |
Employees | 1800 |
CEO | Dr. Kenneth T. Sim M.D. |
Industry | Miscellaneous |
International Select Dividend Ishares
$59.83
-1.25%
Vanguard Ultra Short Bond Et
$59.83
-1.25%
Core Scientific Inc
$59.83
-1.25%
Arbor Realty Trust, Inc.
$59.83
-1.25%
Corvel Corp
$59.83
-1.25%
Invesco S&p 500® Top 50 Etf
$59.83
-1.25%
Invesco S&p 500 Momentum Etf
$59.83
-1.25%
Moog Inc
$59.83
-1.25%
Ardagh Metal Packaging S A
$59.83
-1.25%